FA

Faisal Abul Hasan Khan

Active Director Designated Partner DIN 11031899
DIN 11031899 First appointment Apr 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Faisal Abul Hasan Khan

Data last updated:

Faisal Abul Hasan Khan is a Designated Partner at Cure Inn Pharmaceuticals Llp (since 2025). The company operates in Pharma.

DIN 11031899
Primary Designation Designated Partner
Industry Pharma
First Appointment 01 Apr 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner01 Apr 20252025Active

Board colleagues of Faisal Abul Hasan Khan

NameDINCompanyDesignation
Aadil Firoz Shaikh11031902Cure Inn Pharmaceuticals LlpDesignated Partner
Mo Shahid11031900Cure Inn Pharmaceuticals LlpDesignated Partner
Uneeb Yunus Shaikh11031901Cure Inn Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Cure Inn Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Faisal Abul Hasan Khan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Faisal Abul Hasan Khan

Faisal Abul Hasan Khan currently holds 1 directorship: Cure Inn Pharmaceuticals Llp (Designated Partner, since 01 Apr 2025).

Faisal Abul Hasan Khan was first appointed on 01 Apr 2025 as Designated Partner at Cure Inn Pharmaceuticals Llp.

The current boards of Faisal Abul Hasan Khan's companies include Aadil Firoz Shaikh (Cure Inn Pharmaceuticals Llp), Mo Shahid (Cure Inn Pharmaceuticals Llp), Uneeb Yunus Shaikh (Cure Inn Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available